Long-Term Survival of Cancer Patients Following COVID-19 Infection: Prognostic Value of Inflammatory Indices and Vaccination Status

Read full text Summarise with VIRAT
Authors: Seda Sali, Mehmet Akif Ötegeçeli, Şule Özalp, Ahmet Bilgehan Şahin, Birol Ocak, Mürsel Salı, Eyüp Çoban, Burcu Caner, Sibel Oyucu Orhan, Adem Deligönül, Türkkan Evrensel, Erdem Çubukçu
Cited by: 0
References: 19

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The survival outcomes of cancer patients exposed to Coronavirus Disease 2019 (COVID-19), the duration required to resume oncological treatment, and the subsequent course of their malignancy remain areas with limited data. This retrospective study evaluated 128 cancer patients hospitalized for COVID-19 treatment between April 2020 and October 2023. Of the cohort, 39.8% were women and 60.2% were men. Findings revealed that patients with metastatic lung involvement faced a 3.34-fold increased risk of death during the acute infection. In the post-COVID survival cohort, multivariate analysis indicated that younger age, higher hemoglobin levels, higher systemic inflammatory index, lower pan-immune inflammation value, and absence of active cancer were associated with longer survival. Additionally, vaccine-related survival differences were observed; however, these findings should be interpreted cautiously as they likely reflect confounding factors such as prioritizing high-risk patients for certain vaccine types rather than a direct causal relationship. Notably, while treatment delays were common among patients with disease progression, these delays did not result in a statistically significant difference in overall survival during the long-term follow-up.

Fields of Study & Subjects

COVID-19 and healthcare impacts COVID-19 Clinical Research Studies Inflammatory Biomarkers in Disease Prognosis

Publication details

Journal / source
Uludağ Üniversitesi Tıp Fakültesi Dergisi
Volume
52
Pages
1898579–1898579
Publication date
26 March 2026
Language
EN